CDK Inhibitors in Normal and Malignant Cells

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The present article provides a general review of the function and regulation of the best understood CDK inhibitors, p15INK4b, p16INK4a, p21Cip1, and p27Kip1 in normal cells. Mechanisms of CDK inhibitor regulation in normal cells are briefly reviewed, as is their deregulation and potential prognostic significance in human cancers. The article addresses how CDK inhibitors govern not only cell cycle progression but how they are implicated in regulation of diverse processes, including senescence, programmed cell death, transcription factor corepression and cell motility and invasion. Several of these functions have been shown to be misregulated in cancers and the potential for CDK inhibitor levels or localization to serve as markers/predictors of oncogenic pathway activation and responsiveness to targeted therapies is discussed.

Original languageEnglish (US)
Title of host publicationFunctional Cell Biology
PublisherElsevier Inc.
Pages437-446
Number of pages10
Volume3
ISBN (Electronic)9780123944474
ISBN (Print)9780123947963
DOIs
StatePublished - Jan 1 2015

Fingerprint

Cell Movement
Neoplasms
Cell Cycle
Cell Death
Transcription Factors
Therapeutics

Keywords

  • Cancer
  • CDK
  • CDK inhibitor
  • Cell cycle
  • Cyclin
  • INK4a
  • INK4b
  • MEK/MAPK
  • P21
  • P27
  • PI3K/mTOR
  • Src

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Besser, A., & Slingerland, J. M. (2015). CDK Inhibitors in Normal and Malignant Cells. In Functional Cell Biology (Vol. 3, pp. 437-446). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-394447-4.30059-1

CDK Inhibitors in Normal and Malignant Cells. / Besser, A.; Slingerland, Joyce M.

Functional Cell Biology. Vol. 3 Elsevier Inc., 2015. p. 437-446.

Research output: Chapter in Book/Report/Conference proceedingChapter

Besser, A & Slingerland, JM 2015, CDK Inhibitors in Normal and Malignant Cells. in Functional Cell Biology. vol. 3, Elsevier Inc., pp. 437-446. https://doi.org/10.1016/B978-0-12-394447-4.30059-1
Besser A, Slingerland JM. CDK Inhibitors in Normal and Malignant Cells. In Functional Cell Biology. Vol. 3. Elsevier Inc. 2015. p. 437-446 https://doi.org/10.1016/B978-0-12-394447-4.30059-1
Besser, A. ; Slingerland, Joyce M. / CDK Inhibitors in Normal and Malignant Cells. Functional Cell Biology. Vol. 3 Elsevier Inc., 2015. pp. 437-446
@inbook{3e2ac142341045d3bf8a789e15c5a5f4,
title = "CDK Inhibitors in Normal and Malignant Cells",
abstract = "The present article provides a general review of the function and regulation of the best understood CDK inhibitors, p15INK4b, p16INK4a, p21Cip1, and p27Kip1 in normal cells. Mechanisms of CDK inhibitor regulation in normal cells are briefly reviewed, as is their deregulation and potential prognostic significance in human cancers. The article addresses how CDK inhibitors govern not only cell cycle progression but how they are implicated in regulation of diverse processes, including senescence, programmed cell death, transcription factor corepression and cell motility and invasion. Several of these functions have been shown to be misregulated in cancers and the potential for CDK inhibitor levels or localization to serve as markers/predictors of oncogenic pathway activation and responsiveness to targeted therapies is discussed.",
keywords = "Cancer, CDK, CDK inhibitor, Cell cycle, Cyclin, INK4a, INK4b, MEK/MAPK, P21, P27, PI3K/mTOR, Src",
author = "A. Besser and Slingerland, {Joyce M}",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/B978-0-12-394447-4.30059-1",
language = "English (US)",
isbn = "9780123947963",
volume = "3",
pages = "437--446",
booktitle = "Functional Cell Biology",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - CDK Inhibitors in Normal and Malignant Cells

AU - Besser, A.

AU - Slingerland, Joyce M

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The present article provides a general review of the function and regulation of the best understood CDK inhibitors, p15INK4b, p16INK4a, p21Cip1, and p27Kip1 in normal cells. Mechanisms of CDK inhibitor regulation in normal cells are briefly reviewed, as is their deregulation and potential prognostic significance in human cancers. The article addresses how CDK inhibitors govern not only cell cycle progression but how they are implicated in regulation of diverse processes, including senescence, programmed cell death, transcription factor corepression and cell motility and invasion. Several of these functions have been shown to be misregulated in cancers and the potential for CDK inhibitor levels or localization to serve as markers/predictors of oncogenic pathway activation and responsiveness to targeted therapies is discussed.

AB - The present article provides a general review of the function and regulation of the best understood CDK inhibitors, p15INK4b, p16INK4a, p21Cip1, and p27Kip1 in normal cells. Mechanisms of CDK inhibitor regulation in normal cells are briefly reviewed, as is their deregulation and potential prognostic significance in human cancers. The article addresses how CDK inhibitors govern not only cell cycle progression but how they are implicated in regulation of diverse processes, including senescence, programmed cell death, transcription factor corepression and cell motility and invasion. Several of these functions have been shown to be misregulated in cancers and the potential for CDK inhibitor levels or localization to serve as markers/predictors of oncogenic pathway activation and responsiveness to targeted therapies is discussed.

KW - Cancer

KW - CDK

KW - CDK inhibitor

KW - Cell cycle

KW - Cyclin

KW - INK4a

KW - INK4b

KW - MEK/MAPK

KW - P21

KW - P27

KW - PI3K/mTOR

KW - Src

UR - http://www.scopus.com/inward/record.url?scp=85042769574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042769574&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-394447-4.30059-1

DO - 10.1016/B978-0-12-394447-4.30059-1

M3 - Chapter

SN - 9780123947963

VL - 3

SP - 437

EP - 446

BT - Functional Cell Biology

PB - Elsevier Inc.

ER -